Quest Diagnostics (BSP:Q1UE34) Cyclically Adjusted FCF per Share: R$25.89 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:Q1UE34 Quest Diagnostics Inc BSP:Q1UE34
79 GF Score
Price R$613.80
GF Value R$510.29
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Quest Diagnostics Cyclically Adjusted FCF per Share?

Quest Diagnostics BSP:Q1UE34 79 Cyclically Adjusted FCF per Share is R$25.89 as of Jun. 2026. GuruFocus rates BSP:Q1UE34 with a GF Score™ of 79/100 and a GF Value™ of R$510.29 (Modestly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Quest Diagnostics's adjusted free cash flow per share for the three months ended in Jun. 2026 was R$10.500. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is R$25.89 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Quest Diagnostics's average Cyclically Adjusted FCF Growth Rate was 8.90% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 7.80% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 10.10% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 9.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Quest Diagnostics was 33.00% per year. The lowest was 1.60% per year. And the median was 7.80% per year.

As of today (2026-08-16), Quest Diagnostics's current stock price is R$613.80. Quest Diagnostics's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was R$25.89. Quest Diagnostics's Cyclically Adjusted Price-to-FCF of today is 23.71.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Quest Diagnostics was 23.29. The lowest was 13.17. And the median was 18.21.


Quest Diagnostics  (BSP:Q1UE34) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Quest Diagnostics's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=613.80/25.89
=23.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Quest Diagnostics was 23.29. The lowest was 13.17. And the median was 18.21.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Quest Diagnostics Cyclically Adjusted FCF per Share Related Terms


Quest Diagnostics Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Quest Diagnostics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Diagnostics Cyclically Adjusted FCF per Share Chart

Quest Diagnostics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.71 20.64 22.04 28.63 28.84

Quest Diagnostics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.63 26.06 28.84 27.28 25.89

BSP:Q1UE34 vs LH, MTD, ILMN: Cyclically Adjusted FCF per Share Comparison

For the Diagnostics & Research subindustry, Quest Diagnostics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest Diagnostics Cyclically Adjusted Price-to-FCF vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Quest Diagnostics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Quest Diagnostics's Cyclically Adjusted Price-to-FCF falls into.


BSP:Q1UE34
79GF Score
Quest Diagnostics Inc BSP:Q1UE34
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quest Diagnostics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Quest Diagnostics's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=10.5/333.9520*333.9520
=10.500

Current CPI (Jun. 2026) = 333.9520.

Quest Diagnostics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 2.749 241.428 3.803
201612 2.690 241.432 3.721
201703 1.708 243.801 2.340
201706 2.695 244.955 3.674
201709 3.345 246.819 4.526
201712 2.836 246.524 3.842
201803 1.262 249.554 1.689
201806 3.323 251.989 4.404
201809 4.744 252.439 6.276
201812 2.012 251.233 2.674
201903 3.219 254.202 4.229
201906 3.345 256.143 4.361
201909 3.052 256.759 3.970
201912 2.656 256.974 3.452
202003 2.968 258.115 3.840
202006 5.207 257.797 6.745
202009 15.195 260.280 19.496
202012 7.169 260.474 9.191
202103 13.462 264.877 16.973
202106 7.444 271.696 9.150
202109 9.967 274.310 12.134
202112 7.623 278.802 9.131
202203 8.575 287.504 9.960
202206 6.914 296.311 7.792
202209 8.532 296.808 9.600
202212 4.265 296.797 4.799
202303 -0.761 301.836 -0.842
202306 7.238 305.109 7.922
202309 2.209 307.789 2.397
202312 9.953 306.746 10.836
202403 1.112 312.332 1.189
202406 6.444 314.175 6.850
202409 6.126 315.301 6.488
202412 8.967 315.605 9.488
202503 5.019 319.799 5.241
202506 10.699 322.561 11.077
202509 9.943 324.800 10.223
202512 7.411 324.054 7.637
202603 3.829 330.213 3.872
202606 10.500 333.952 10.500

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of R$25.89 mean?
Quest Diagnostics (BSP:Q1UE34) has a Cyclically Adjusted FCF per Share of R$25.89 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Quest Diagnostics and its competitors.
Is Quest Diagnostics' Cyclically Adjusted FCF per Share too high?
Quest Diagnostics' current Cyclically Adjusted FCF per Share is R$25.89. Overall, Quest Diagnostics has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Quest Diagnostics' Cyclically Adjusted FCF per Share compare to LH and MTD?
Quest Diagnostics' Cyclically Adjusted FCF per Share of R$25.89 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted FCF per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Quest Diagnostics and its competitors. Quest Diagnostics's current Cyclically Adjusted FCF per Share is R$25.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Quest Diagnostics (BSP:Q1UE34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$510.29, compared to a current price of R$613.80 — trading 20.3% above its estimated fair value. The current Cyclically Adjusted FCF per Share is R$25.89. Quest Diagnostics' overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Quest Diagnostics (BSP:Q1UE34), the current Cyclically Adjusted FCF per Share is R$25.89 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Quest Diagnostics (BSP:Q1UE34) Overvalued in 2026?

Based on GuruFocus' analysis, Quest Diagnostics stock appears to be overvalued. The current stock price of R$613.80 is trading 20.3% above its estimated GF Value™ of R$510.29. GuruFocus considers Quest Diagnostics to be Modestly Overvalued.

Key valuation signals for BSP:Q1UE34:

  • Cyclically Adjusted FCF per Share: R$25.89
  • GF Value™: R$510.29 vs. price of R$613.80 (20.3% above fair value)
  • GF Score™: 79/100 with 7 warning signs

No single metric tells the full story. See the BSP:Q1UE34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Quest Diagnostics Business Description

Address 500 Plaza Drive, Secaucus, NJ, USA, 07094
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
79GF Score

Get the complete analysis for BSP:Q1UE34

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$613.80
Price
R$510.29
GF Value